Foreign Asset/Account Exchange Control and Tax Reporting Clause Example from Business Contracts
This example Foreign Asset/Account Exchange Control and Tax Reporting clause appears in
4 contracts
from
1 company
Foreign Asset/Account Exchange Control and Tax Reporting. You may be subject to foreign asset/account, exchange control and/or tax reporting requirements as a result of the acquisition, holding and/or transfer of Ordinary Shares or cash (including dividends and the proceeds arising from the sale of Ordinary Shares) derived from your participation in the Plan in, to and/or from a brokerage/bank account or legal entity located outside your country. The Applicable Laws in your country may require that you report such accounts, assets and balances therein,
... the value thereof and/or the transactions related thereto to the applicable authorities in such country. You may also be required to repatriate sale proceeds or other funds received as a result of your participation in the Plan to your country through a designated bank or broker within a certain time after receipt. You acknowledge that it is your responsibility to be compliant with such regulations and you are encouraged to consult with your personal legal advisor for any details.
View More
Horizon Pharma plc Contracts
Horizon Therapeutics Public Limited Company Amended and Restated 2020 Equity Incentive Plan and Form of Option Agreement, Form of Stock Option Grant Notice, Forms of Restricted...
(Filed With SEC on November 3, 2021)
Horizon Therapeutics Public Limited Company Amended and Restated 2018 Equity Incentive Plan (assumed from Viela Bio, Inc.) and Form of RSU Award Grant Notice and Form of Award...
(Filed With SEC on November 3, 2021)
Horizon Therapeutics Public Limited Company Amended and Restated 2020 Equity Incentive Plan, as amended, and 2020 Restricted Stock Unit Award Sub-Plan and Form of Option...
(Filed With SEC on March 1, 2022)
Horizon Therapeutics Public Limited Company Amended and Restated 2018 Equity Incentive Plan (assumed from Viela Bio, Inc.), as amended, and 2018 Restricted Stock Unit Award...
(Filed With SEC on March 1, 2022)